Oslo Norway
Cultural & Informational Centers · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
CanadaWebsite
www.oslo-norway.caRevenue
$7.5 MillionIndustry
About Oslo Norway
Oslo Norway Org Chart
Is Oslo Norway your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Oslo Norway
Check out if Oslo Norway is spiking on competitors!
Oslo Norway, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Oslo Norway recently announced quarterly report
Check if Oslo Norway has recently received funding, and reach out quickly before it becomes old news!
Click to see if Oslo Norway had a recent Job posting/layoffs
Product Launch: Get notified when Oslo Norway launches new products
Funding: Get notified immidiatlly once Oslo Norway has new funding data
Recommended Actions
Find VP level buyers at Oslo Norway
Find 3 more new buyers
Compare Similar Companies to Oslo Norway
Compare insights from companies similar to Oslo Norway, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Oslo Norway is experiencing very low activity levels compared to other companies in the Hospitality sector.
What does this means?
Oslo Norway is drawing exceptional interest within the Hospitality industry, suggesting notable developments or strong market momentum, learn more about Oslo Norway.
Oslo Norway Tech Stack
A closer look at the technologies used by Oslo Norway
Oslo Norway News & Media
Calluna Pharma appoints Mark Gaffney as Chief Executive Officer and Mark Altmeyer as Independent Chair of the Board
OSLO, Norway & BOSTON--(BUSINESS WIRE)--Calluna Pharma AS (Calluna), a clinical stage biotechnology company pioneering first-in-class antibodies to treat inflammatory and fibrotic diseases, today announced the appointments of Mark Gaffney as Chief Executive Officer and Mark Altmeyer as Chair of the Board. Alongside these appointments, John Montana, who has been acting as the Company's interim CEO, will return to his role as an Operating Partner at Forbion. Gaffney brings over 20 years of experi
Top Cultural & Informational Centers Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Oslo Norway
Oslo Norway Tourist Information and Travel Guide provides comprehensive information about the city's landmarks, attractions, museums, and recreational activities. It highlights popular sites such as Akershus Castle, the Nobel Peace Centre, and the Munch Museum, catering to tourists seeking to explore Oslo. The guide also offers insights into accomm... Read More